Suppression of menstruation in adolescents with severe learning disabilities

Archives of Disease in Childhood

Volumn 92, Issue 7, 2007, Pages 629-632

  Albanese, Assunta ^a   Hopper, Neil W ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN DERIVATIVE; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; PROGESTERONE;

ADOLESCENT; BREAKTHROUGH BLEEDING; CANCER RISK; COGNITIVE DEFECT; DISEASE SEVERITY; ENDOMETRIUM ABLATION; FEMALE; HUMAN; LEARNING DISORDER; MENSTRUATION; PRIORITY JOURNAL; REVIEW; SECONDARY AMENORRHEA; WEIGHT GAIN;

ADOLESCENT; CONTRACEPTIVE AGENTS, FEMALE; DEVELOPMENTAL DISABILITIES; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; LEARNING DISORDERS; MEDROXYPROGESTERONE 17-ACETATE; MENSTRUATION; OVULATION INHIBITION;

EID: 34347357643     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2007.115709     Document Type: Review

References (35)

1. Quint EH. The conservative management of abnormal bleeding in teenagers with developmental disabilities. J Pediatr Adolesc Gynecol 2003;16(1):54-6.
2. Dizon CD, Allen LM, Ornstein MP. Menstrual and contraceptive issues among young women with developmental delay: a retrospective review of cases at the Hospital for Sick Children, Toronto. J Pediatr Adolesc Gynecol 2005;18(3):157-62.
3. Servais L, Jacques D, Leach R, et al. Contraception of women with intellectual disability: prevalence and determinants. J Intelled Disabil Res 2002;46(Pt 2):108-19.
4. Backeljauw P, Rose S, Lawson M. Clinical management of menstruation in adolescent females with developmental delay. Endocrinologist 2004;14(2):87-92.
5. Davies JH, Evans BA, Gregory JW. Bone mass acquisition in healthy children. Arch Dis Child 2005;90(4):373-8.
6. Bonny AE, Harkness LS, Cromer BA. Depot medroxyprogesterone acetate: implications for weight status and bone mineral density in the adolescent female. Adotesc Med Clin 2005;16(3):569-84.
7. Lara-Torre E, Edwards CP, Perlman S, et al. Bone mineral density in adolescent females using depot medroxyprogesterone acetate. J Pediatr Adolesc Gynecol 2004;17(1):17-21.
8. Cromer BA. Bone mineral density in adolescent and young adult women on injectable or oral contraception. Curr Opin Obstet Gynecol 2003;15(5):353-7.
9. Scholes D, LaCroix AZ, Ichikawa LE, et al. Injectable hormone contraception and bone density: results from a prospective study. Epidemiology 2002;13(5):581-7.
10. Scholes D, LaCroix AZ, Ichikawa LE, et al. Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception. Arch Pediatr Adolesc Med 2005;159(2):139-44.
11. Courteix D, Lespessailles E, Peres SL, et al. Effect of physical training on bone mineral density in prepubertal girls: a comparative study between impact-loading and non-impact-loading sports. Osteoporos Int 1998;8(2):152-8.
12. Center J, Beange H, McElduff A. People with mental retardation have an increased prevalence of osteoporosis: a population study. Am J Ment Retard 1998;103(1):19-28.
13. Aspray TJ, Francis RM, Thompson A, et al. Comparison of ultrasound measurement at the heel between adults with mental retardation and control subjects. Bone 1998;22(6):665-8.
14. Sheth RD. Metabolic concerns associated with antiepileptic medications. Neurology 2004;63(10 Suppl 4):S24-9.
15. Bonny AE, Britto MT, Huang B, et al. Weight gain, adiposity, and eating behaviors among adolescent females on depot medroxyprogesterone acetate (DMPA). J Pediatr Adolesc Gynecol 2004;17(2):109-15.
16. Edelman AB, Gallo MF, Jensen JT, et al. Continuous or extended cycle vs. cyclic use of combined oral contraceptives for contraception. Cochrane Database Syst Rev 2005;(3):CD004695.
17. Gomes MP, Deitcher SR. Risk of thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review. Arch Intern Med 2004;164(18):1965.
18. Burkman R, Schlesselmann JJ, Zieman M. Safety concerns and health benefits associated with oral contraception. Am J Obstet Gynecol 2004;190(Suppl 4):S5-22.
19. Cromer BA, Stager M, Bonny A, et al. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent gids. J Adolesc Health 2004;35(6):434-41.
20. Sagsveen M, Farmer JE, Prentice A, et al. Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density. Cochrane DataBase Syst Rev 2003;(4):CD001297.
21. Heikkinen JE, Vaheri RT, Ahomaki SM, et al. Optimizing continuous-combined hormone replacement therapy for postmenopausal women: a comparison of six different treatment regimens. Am J Obstet Gynecol 2000;182(3):560-7.
22. van der Sluis IM, Boot AM, Krenning EP, et al. Longitudinal follow-up of bone density and body composition in children with precocious or early puberty before, during and after cessation of GnRH agonist therapy. J Clin Endocrinol Metab 2002;87(2):506-12.
23. Antoniazzi F, Zamboni G, Bertoldo F, et al. Bone development during GH and GnRH analog treatment. Eur J Endocrinol 2004;151(Suppl 1):S47-54.
24. Bridges NA, Cooke A, Healy MJ, et al. Ovaries in sexual precocity. Clin Endocrinol (Oxf) 1995;42(2):135-40.
25. Luukkainen T. The levonorgesfrel intrauterine system: therapeutic aspects. Steroids 2000;65(10-11):699-702.
26. Hidalgo M, Bahamondes L, Perrotti M, et al. Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years. Contraception 2002;65(2):129-32.
27. Hurskainen R, Poavonen J. Levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding. Curr Opin Obstet Gynecol 2004;16(6):487-90.
28. Committee on Bioethics. Sterilization of minors with developmental disabilities. American Academy of Pediatrics. Committee on Bioethics. Pediatrics 1999;104(2 Pt 1):337-40.
29. Skinner SR, Ng C, McDonald A, et al. A patient with autism and severe depression: medical and ethical challenges for an adolescent medicine unit. Med J Aust 2005;183(8):422-4.
30. Gillon R. On sterilising severely mentally handicapped people. J Med Ethics 1987;13(2):59-61.
31. Brahams D. Legal power to sterilise incompetent women. Lancet 1989;1(8642):854-5.
32. Dyer C. Sterilisation of mentally handicapped woman. BMJ (Clin Res Ed) 1987;294(6575):825.
33. Dyer C. Sterilisation of mentally handicapped girl authorised. BMJ (Clin Res Ed) 1987;294(6581):1219.
34. Dyer C. Law lords give reasons for their decision on consent. BMJ 1989;298(6687):1542.
35. Dyer C. Sterilisation of mentally handicapped adults. BMJ 1988;297(6662):1494.